Erytech Pharma S.A. Stock
Your prediction
Erytech Pharma S.A. Stock
Our community identified positive and negative aspects for Erytech Pharma S.A. stock for the coming years. 2 users see the criterium "Worthwhile Investment for the next years" as a plus for the Erytech Pharma S.A. stock. On the other hand our users think that "Worthwhile Investment for the next years" could be a problem in the future.
Pros and Cons of Erytech Pharma S.A. in the next few years
Pros
?
S********** s********
?
W********* I********* f** t** n*** y****
?
B****
Cons
?
G***** c******* t* c**********
?
C******** o* t** e**********
?
M***** P*******
Tell us your opinion to access the 'Wisdom of the Crowds'
Performance of Erytech Pharma S.A. vs. its peers
| Security | Change(%) | 1w | 1m | 1y | YTD | 3y | 5y |
|---|---|---|---|---|---|---|---|
| Erytech Pharma S.A. | - | - | - | - | - | - | - |
| Nanobiotix | 2.170% | 3.350% | 6.618% | 849.264% | 51.832% | 427.273% | 134.438% |
| Innate Pharma | 0.790% | 4.631% | 5.903% | -35.654% | -20.261% | -53.435% | -64.473% |
| Poxel S.A. | 1.430% | -1.389% | -11.566% | -34.862% | 3.975% | -60.928% | -96.203% |
